All Business articles – Page 29
-
BusinessCholesterol drug withdrawn in patent dispute
Ruling that Regeneron’s Praluent antibody infringes Amgen’s Repatha patent could stifle innovation
-
BusinessIpsen to buy Merrimack’s cancer drugs
$1bn deal covers two liposome-encapsulated formulations of approved therapies
-
BusinessTaming vaccines with chemistry
Vaxxilon aims to simplify vaccine development by replacing biological components with well-defined synthetic molecules
-
BusinessTakeda to buy cancer specialist Ariad
Japan’s largest drug company agrees $5.2bn deal to expand oncology portfolio and boost pipeline
-
BusinessMosaic to buy Vale Fertilizantes in $2.5bn deal
Fertiliser deal continues consolidation trend and expands Mosaic’s presence in Brazil
-
BusinessLinde–Praxair merger further consolidates industrial gases
Deal will leave just three firms controlling 85% of the global market
-
BusinessShell fined $22m for drinking water contamination
Jury rules in favour of US city of Clovis over 1,2,3-trichloropropane contamination, while rejecting punitive damages
-
BusinessIndian court revokes ban on combination drugs
Companies claim government failed to follow procedure in restricting risky medicines
-
BusinessTeva fined $520m for corruption
World’s largest generics manufacturer admits paying bribes in Russia, Ukraine and Mexico
-
-
BusinessDuPont found liable in third bellwether cancer case
US court orders firm to pay $2m in damages to man whose disease has been linked to contaminated water supply
-
BusinessMylan may lay off up to 3500 staff
The move forms part of the US generic firm’s restructuring efforts
-
-
BusinessLonza to buy capsule manufacturer in $5.5bn deal
Swiss pharma firm looks to strengthen its position as world’s biggest drug manufacturing subcontractor
-
BusinessUS pharma executives face bribery charges over opioid painkiller prescriptions
Insys Therapeutics chief executive and senior managers accused of running a conspiracy to bribe doctors across several states
-
BusinessBristol-Myers Squibb planning huge reorganisation in the US
Job losses likely as Hopewell, New Jersey site will close by 2020
-
BusinessSyngenta subsidiary faces fine over pesticide exposure
US environment agency wants firm to pay $5 million after workers hospitalised after coming into contact with chlorpyrifos
-
BusinessPharmaceutical industry roundup of 2016
Controversial approvals and price clashes characterised 2016 in pharma
-
BusinessDeath sentence for head of Tianjin explosion firm
48 Ruihai Logistics staff and government officials also sentenced
-
BusinessWashington state sues Monsanto over PCBs
Attorney general wants to recoup damages and cleanup costs related to polychlorinated biphenyls